Lack of the effect of bumetanide, a selective NKCC1 inhibitor, in patients with schizophrenia: A double‐blind randomized trial. Issue 1 (21st December 2016) - Rahmanzadeh, Reza; Shahbazi, Ali; Ardakani, Mohammad‐reza Khodaei; Mehrabi, Soraya; Rahmanzade, Ramin; Joghataei, Mohammad Taghi